TD Cowen Downgrades Reata Pharmaceuticals (RETA) to Market Perform
Tweet Send to a Friend
TD Cowen analyst Tyler Van Buren downgraded Reata Pharmaceuticals (NASDAQ: RETA) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
